M. Waaijers

发表

A. Bogers, S. Lamberts, L. Hofland, 2000, American journal of physiology. Endocrinology and metabolism.

Crucial role for somatostatin receptor subtype 2 in determining the uptake of [111In-DTPA-D-Phe1]octreotide in somatostatin receptor-positive organs.

E. Krenning, S. Lamberts, W. Breeman, 2003, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

IFN-β Is a Highly Potent Inhibitor of Gastroenteropancreatic Neuroendocrine Tumor Cell Growth In vitro

G. Vitale, S. Lamberts, E. Croze, 2006 .

IFN-B Is a Highly Potent Inhibitor of Gastroenteropancreatic Neuroendocrine Tumor Cell Growth In vitro

G. Vitale, S. Lamberts, E. Croze, 2005 .

Distinct functional properties of native somatostatin receptor subtype 5 compared with subtype 2 in the regulation of ACTH release by corticotroph tumor cells.

D. Hoyer, S. Lamberts, M. Culler, 2005, American journal of physiology. Endocrinology and metabolism.

Internalization of the radioiodinated somatostatin analog [125I-Tyr3]octreotide by mouse and human pituitary tumor cells: increase by unlabeled octreotide.

S. Lamberts, W. Breeman, P. V. van Koetsveld, 1995, Endocrinology.

Dopamine D2 receptor expression in the corticotroph cells of the human normal pituitary gland

J. Kros, S. Lamberts, L. Hofland, 2017, Endocrine.

The novel somatostatin analog SOM230 is a potent inhibitor of hormone release by growth hormone- and prolactin-secreting pituitary adenomas in vitro.

S. Lamberts, A. J. van der Lely, P. V. van Koetsveld, 2004, The Journal of clinical endocrinology and metabolism.

Immunoreactivity score using an anti-sst2A receptor monoclonal antibody strongly predicts the biochemical response to adjuvant treatment with somatostatin analogs in acromegaly.

J. Kros, F. Minuto, L. Hofland, 2013, The Journal of clinical endocrinology and metabolism.

in the normal human thymus Age-related decrease of somatostatin receptor number

A. Bogers, L. Hofland, G. Lombardi, 2006 .

The multi-ligand somatostatin analogue SOM230 inhibits ACTH secretion by cultured human corticotroph adenomas via somatostatin receptor type 5.

S. Lamberts, P. V. van Koetsveld, L. Hofland, 2005, European journal of endocrinology.

Interferon-alpha-2a is a potent inhibitor of hormone secretion by cultured human pituitary adenomas.

S. Lamberts, P. V. van Koetsveld, L. Hofland, 1999, The Journal of clinical endocrinology and metabolism.

Interferon-a-2 a Is a Potent Inhibitor of Hormone Secretion by Cultured Human Pituitary Adenomas

S. Lamberts, L. Hofland, P. Uitterlinden, 1999 .

Long‐term in‐vitro treatment of human growth hormone (GH)‐secreting pituitary adenoma cells with octreotide causes accumulation of intracellular GH and GH mRNA levels

E. Hooghe-Peters, B. Velkeniers, S. Lamberts, 1992, Clinical Endocrinology.

Internalization of [DOTA degrees,125I-Tyr3]Octreotide by somatostatin receptor-positive cells in vitro and in vivo: implications for somatostatin receptor-targeted radio-guided surgery.

E. Krenning, S. Lamberts, W. Breeman, 1999, Proceedings of the Association of American Physicians.

Quantitative and functional expression of somatostatin receptor subtypes in human thymocytes.

S. Lamberts, F. Minuto, P. V. van Koetsveld, 2002, American journal of physiology. Endocrinology and metabolism.

Dissociation of antiproliferative and antihormonal effects of the somatostatin analog octreotide on 7315b pituitary tumor cells.

S. Lamberts, J. Reubi, P. V. van Koetsveld, 1992, Endocrinology.

Dopamine receptor expression and function in human normal adrenal gland and adrenal tumors.

S. Lamberts, P. V. van Koetsveld, L. Hofland, 2004, The Journal of clinical endocrinology and metabolism.

Interferon-β is a potent inhibitor of cell growth and cortisol production in vitro and sensitizes human adrenocortical carcinoma cells to mitotane.

G. Vitale, E. Speel, S. Lamberts, 2013, Endocrine-related cancer.

Internalisation of isotope-coupled somatostatin analogues.

S. Lamberts, P. V. van Koetsveld, L. Hofland, 1996, Digestion.

Potent inhibitory effects of type I interferons on human adrenocortical carcinoma cell growth.

G. Vitale, C. V. van Eijck, S. Lamberts, 2006, The Journal of clinical endocrinology and metabolism.

The role of mTOR inhibitors in the inhibition of growth and cortisol secretion in human adrenocortical carcinoma cells.

M. D. De Martino, S. Lamberts, P. V. van Koetsveld, 2012, Endocrine-related cancer.

Dissociation between the effects of somatostatin (SS) and octapeptide SS-analogs on hormone release in a small subgroup of pituitary- and islet cell tumors.

S. Lamberts, P. V. van Koetsveld, L. Hofland, 1997, The Journal of clinical endocrinology and metabolism.

Relative potencies of the somatostatin analogs octreotide, BIM-23014, and RC-160 on the inhibition of hormone release by cultured human endocrine tumor cells and normal rat anterior pituitary cells.

S. Lamberts, P. V. van Koetsveld, L. Hofland, 1994, Endocrinology.

Vitro in Release by Growth Hormone- and Prolactin-Secreting Pituitary Adenomas The Novel Somatostatin Analog SOM230 Is a Potent Inhibitor of Hormone

S. Lamberts, L. Hofland, A. Beckers, 2004 .

Somatostatin receptors in malignant lymphomas: targets for radiotherapy?

F. Staal, A. Langerak, S. Lamberts, 2004, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

The novel somatostatin analog SOM230 has a broad spectrum of inhibitory action on hormone release by human somatotroph, corticotroph and PRL-secreting pituitary adenomas in vitro

S. Lamberts, L. Hofland, A. Beckers, 2003 .

IFN-beta is a highly potent inhibitor of gastroenteropancreatic neuroendocrine tumor cell growth in vitro.

G. Vitale, S. Lamberts, E. Croze, 2006, Cancer research.

Characterization of the mTOR pathway in human normal adrenal and adrenocortical tumors.

M. D. De Martino, S. Lamberts, P. V. van Koetsveld, 2014, Endocrine-related cancer.